Skip to main content
. 2017 Jun 15;8(6):e99. doi: 10.1038/ctg.2017.25

Figure 2.

Figure 2

Elevation in hepatic cathepsin L (CTSL) and cathepsin B (CTSB) expression in patients with liver cirrhosis. (a, b) Immunohistochemical localization of CTSL and CTSB in the human liver biopsies. In control liver tissue (n=13), punctuate pericanalicular cytoplasmic CTSL and CTSB expression was observed in hepatocytes (arrow), along with mild focal positivity in bile duct epithelial cells, and kupffer cells. Similar to controls, mild CTSL and CTSB immunoreactivity is seen in patients with chronic hepatitis (CVH, n=10). Whereas strong and diffuse immunostaining for both these proteases was evident in hepatocytes, ductal cells, infiltrating histiocytes, and fibrotic septae (indicated by arrows) in the liver of cirrhotic subjects (n=28) (Original magnification, × 200). (c, d) Total immunoscores of (c) CTSL and (d) CTSB were significantly higher in patients with liver cirrhosis compared with controls and CVH patients (mean±s.e.m., **P≤0.001 and ***P≤0.0001, scores of fibrotic patients vs. the corresponding non-fibrotic controls, Kruskal–Wallis H test was used to compare the means of all the groups).